IonQ, Inc. — FY2022 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2022. The filing was signed March 30, 2023. Unless noted otherwise, financial amounts below are in U.S. dollars.
Business context
IonQ develops trapped-ion quantum computers and sells access through quantum-computing-as-a-service (QCaaS), consulting and development services, and some specialized hardware. Access is offered through AWS, Microsoft Azure and Google Cloud, as well as directly to select customers. The company remains at an early commercial stage; broader commercialization depends on technical progress and customer adoption.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $11.1 million | $2.1 million |
| Cost of revenue, excluding depreciation and amortization | $2.9 million | $1.0 million |
| Research and development | $44.0 million | $20.2 million |
| Sales and marketing | $8.4 million | $3.2 million |
| General and administrative | $36.0 million | $13.7 million |
| Operating loss | $85.7 million | $38.7 million |
| Net loss | $48.5 million | $106.2 million |
| Net loss per share, basic and diluted | $0.25 | $0.77 |
| Net cash used in operating activities | $44.7 million | $26.5 million |
Revenue grew 430%, driven by new contracts, increased cloud-provider revenue and services under the University of Maryland agreement. Cost of revenue was about 26% of revenue, implying an approximate 74% margin before depreciation and amortization; this is not a reported GAAP gross margin. Operating expenses rose substantially, with higher headcount, research activity and public-company costs contributing. Stock-based compensation expense, net of amounts capitalized, was $31.5 million in 2022.
Net loss narrowed chiefly because warrant-liability remeasurement shifted from a $63.3 million expense in 2021 to a $30.1 million gain in 2022, and interest income increased to $7.1 million. These non-operating items do not indicate improved operating profitability: operating loss more than doubled.
At year-end, cash, cash equivalents and available-for-sale investments totaled $537.8 million; restricted cash of $2.0 million was additional but excluded from that liquidity figure. Total liabilities were $29.8 million, including $3.8 million of warrant liabilities and operating lease liabilities; the filing reports no borrowings. Operating cash use was $44.7 million. Investing cash use was $309.1 million, primarily reflecting purchases of investments net of maturities and sales. Management said available liquidity was expected to meet working-capital and capital-expenditure needs for the next 12 months, subject to its projections and changing conditions. Accumulated deficit was $194.3 million.
Material changes and notable items
- Revenue increased to $11.1 million from $2.1 million, while operating expenses rose to $96.9 million from $40.8 million.
- Cash and cash equivalents fell to $44.4 million from $399.0 million, while short- and long-term investments increased to $493.4 million combined. Total cash, cash equivalents and investments were $537.8 million at year-end.
- Unrealized losses on available-for-sale securities contributed $7.2 million to other comprehensive loss in 2022, primarily reflecting interest-rate movements; the company did not consider the investments other-than-temporarily impaired.
- IonQ acquired Entangled Networks Ltd.’s assets for $1.0 million in December 2022 to support computation across distributed quantum processors.
- Revenue from the University of Maryland, a related party, was $4.0 million, approximately 36% of FY2022 revenue. Revenue was primarily from three significant customers; customer-level amounts are not clearly stated in the filing text provided.
- The company reported that a previously identified material weakness in its financial-statement close process was remediated and that internal control over financial reporting was effective at December 31, 2022. The auditor did not provide an internal-control attestation because IonQ qualified for the emerging-growth-company exemption.
Outlook, risks and contingencies
IonQ provided no specific FY2023 revenue or earnings guidance in the text provided. Management expects significant losses and higher operating expenses for the foreseeable future. The filing states that significant production and delivery of quantum computers was not expected before 2025 at the earliest, and might occur later or not at all. As of year-end, remaining performance obligations were approximately $30.5 million, including funded and unfunded orders; IonQ expected about 60% to be recognized within 12 months. These obligations are not equivalent to guaranteed future revenue.
- Technology and commercialization: IonQ has not produced a scalable quantum computer or achieved broad quantum advantage. Its roadmap depends on technical advances in fidelity, error correction, system scaling and photonic interconnects; milestones may be delayed or prove unattainable.
- Funding and execution: The company expects continued cash use and may need additional capital. Financing could be unavailable or dilutive. Scaling manufacturing, sourcing components and isotopically enriched materials, and recruiting specialized employees are key execution risks.
- Competition and partnerships: Larger technology companies and other quantum-computing firms may outpace IonQ. The company relies on public-cloud partners that also pursue quantum-computing products.
- Legal matters: Consolidated securities class actions filed in 2022 seek damages; defendants moved to dismiss in February 2023, and management says it will defend the claims. IonQ said it could not reasonably estimate a possible loss or range of loss. A separate legacy dMY-related lawsuit remains pending; management did not believe its resolution would materially adversely affect the company. In March 2023, the Delaware Court of Chancery granted IonQ’s petition validating its 2021 certificate of incorporation and shares issued in reliance on it.
- Banking and macroeconomic risks: IonQ disclosed limited exposure to Silicon Valley Bank before depositors were protected by the FDIC and said it was transferring accounts to additional banks. Inflation, higher interest rates, supply constraints and economic volatility could raise costs or affect financing and customer demand.
- Other exposures: The filing highlights cybersecurity and data-privacy risks, government-contracting and regulatory requirements, intellectual-property licensing dependence, and potential dilution from equity awards and warrants.
Important facts for investors to verify
- Whether revenue growth converts into repeatable commercial demand, and how much is concentrated in a small number of customers or related-party agreements.
- Progress against technical milestones and the roadmap, especially scalable systems, fidelity, error correction and interconnects; distinguish demonstrated results from targets and management beliefs.
- Cash use and investment liquidity, including the timing and funding status of the $30.5 million remaining performance obligations and the assumptions behind management’s 12-month liquidity assessment.
- Developments in the securities litigation, the accounting and cash implications of any resolution, and the status of banking diversification.
- Future stock-based compensation, share issuance and warrant dilution; FY2022 stock-based compensation was $31.5 million and 5.2 million public warrants remained outstanding at year-end.